A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization

C E Tognon1, M J Martin, A Moradian

  • 1Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada.

Oncogene
|August 2, 2011
PubMed

Insights

The ETV6-NTRK3 (EN) oncoprotein requires insulin-like growth factor 1 receptor (IGF1R) and insulin receptor substrate 1 (IRS1) to localize to the cell membrane, driving cancer. Inhibiting IGF1R kinase activity may offer a new cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • ETV6-NTRK3 (EN) is a potent oncoprotein driving various cancers.
  • Insulin-like growth factor 1 receptor (IGF1R) and insulin receptor substrate 1 (IRS1) are crucial for EN-mediated oncogenesis.

Purpose of the Study:

  • To investigate the mechanism by which IRS1 facilitates EN localization to IGF1R at the plasma membrane.
  • To elucidate the role of the EN/IRS1/IGF1R complex in activating phosphatidylinositol 3-kinase (PI3K)-Akt signaling for oncogenesis.

Main Methods:

  • Analysis of EN/IRS1/IGF1R complexes in transformed cells.
  • Assessment of EN transformation activity and cell survival using IGF1R/INSR inhibitor BMS-536924.
  • Co-localization studies of EN and IGF1R at the plasma membrane.

Main Results:

  • Both IRS1 and active IGF1R kinase are essential for EN-mediated cell transformation.
  • Tyrosine-phosphorylated IRS1 forms high molecular weight complexes with EN and IGF1R.
  • EN colocalizes with IGF1R at the plasma membrane, dependent on IGF1R kinase activity and Y950 residue.
  • BMS-536924 inhibits EN transformation, cell survival, and IRS protein interaction, causing a shift in EN complex size.

Conclusions:

  • A tripartite complex of EN, IRS1, and IGF1R is essential for localizing EN to the membrane and driving transformation.
  • This interaction explains the dependence of EN-driven tumors on IGF1R.
  • Targeting IGF1R kinase activity presents a potential therapeutic strategy for EN-driven cancers.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Protein Translocation Machinery on the ER Membrane01:28

Protein Translocation Machinery on the ER Membrane

The translocon complex situated on the ER membrane is the main gateway for the protein secretory pathway. It facilitates the transport of nascent peptides into the ER lumen and their insertion into the ER membrane.
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the translocon complex.
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Tail-anchoring of Proteins in the ER Membrane01:45

Tail-anchoring of Proteins in the ER Membrane

Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...